INCYTE CORP is 2.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($21.23 B vs $8.97 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CRL | INCY |
|---|---|---|
| Market cap | $8.97 B | $21.23 B |
| US-listed rank | #1006 | #595 |
| Revenue (latest FY) | $4.02B | $5.14B |
| Net income (latest FY) | -$144.34M | $1.29B |
| Net margin | -3.6% | 25.0% |
| P/E (trailing FY) | - | 16.5 |
| SEC filings | 2,387 | 2,536 |
INCYTE CORP is 2.4x more valuable than CHARLES RIVER LABORATORIES INTERNATIONAL, INC. by market capitalization ($21.23 B vs $8.97 B).
In their latest fiscal years, CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported $4.02B in revenue while INCYTE CORP reported $5.14B.
Full pages: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and INCYTE CORP, or browse the full rankings.